<?xml version="1.0" encoding="UTF-8"?>
<abstract>
 <title>Abstract</title>
 <sec sec-type="background">
  <title>Background:</title>
  <p>Breast cancer, a malignant disorder, occurs in the epithelial tissue of the breast gland. Chemotherapy is the standard treatment for breast cancer, however, the side effect, especially gastrointestinal dysfunction, due to chemotherapy still remain major problems. Traditional Chinese Medicine has been proven therapeutically effective on reducing adverse effects caused by chemotherapy. Shenhuang Plaster</p>
 </sec>
 <sec sec-type="methods">
  <title>Methods:</title>
  <p>The study is a randomized, placebo-controlled, blind trial. A total of 160 Chinese breast cancer patients will be enrolled and randomly allocated into the experimental group and control group in a 1:1 ratio. Patients in the experimental group will be prescribed Shenhuang plaster application on shenque point (CV8) plus chemotherapy treatment. Patients in the control group will be prescribed placebo plaster application on CV8 plus chemotherapy treatment. The acupoint application will last 3â€Šdays. The primary outcome will be the form of faces every day, and the secondary outcomes the symptom score of traditional Chinese medicine, the changes of fecal bacteria and metabolites, serum motilin, gastrin and ghrelin levels.</p>
 </sec>
 <sec sec-type="discussion">
  <title>Discussion:</title>
  <p>This study is to observe therapeutic effects with Shenhuang plaster application on CV8 to regulate chemotherapy-induced gastrointestinal toxicity in breast cancer patients.</p>
 </sec>
 <sec>
  <title>Trial registration:</title>
  <p>Chinese Clinical Trial Registry (
   <ext-link ext-link-type="uri" xlink:href="http://www.chictr.org.cn/showproj.aspx?proj=55262" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.chictr.org.cn/showproj.aspx?proj=55262</ext-link>) No. ChiCTR2000034313. Registered on July 2, 2020.
  </p>
 </sec>
</abstract>
